These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27227074)

  • 21. In vivo assessment of antiemetic drugs and mechanism of lycorine-induced nausea and emesis.
    Kretzing S; Abraham G; Seiwert B; Ungemach FR; Krügel U; Teichert J; Regenthal R
    Arch Toxicol; 2011 Dec; 85(12):1565-73. PubMed ID: 21626407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ondansetron/promethazine combination or promethazine alone reduces nausea and vomiting after middle ear surgery.
    Khalil S; Philbrook L; Rabb M; Wells L; Aves T; Villanueva G; Amhan M; Chuang AZ; Lemak NA
    J Clin Anesth; 1999 Nov; 11(7):596-600. PubMed ID: 10624646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ondansetron versus droperidol. Postoperative treatment against nausea and vomiting. Comparison of action, adverse effects and acceptance by gynecologic inpatients].
    Heim C; Münzer T; Listyo R
    Anaesthesist; 1994 Aug; 43(8):504-9. PubMed ID: 7978173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double-blind, noninferiority trial.
    Braude D; Crandall C
    Acad Emerg Med; 2008 Mar; 15(3):209-15. PubMed ID: 18304050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness.
    Figueredo E; Canosa L
    Eur J Anaesthesiol; 1999 Aug; 16(8):556-64. PubMed ID: 10500947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy. The French Ondansetron Study Group.
    Lebeau B; Depierre A; Giovannini M; Rivière A; Kaluzinski L; Votan B; Hédouin M; d'Allens H
    Ann Oncol; 1997 Sep; 8(9):887-92. PubMed ID: 9358940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew).
    Rudd JA; Ngan MP; Lu Z; Higgins GA; Giuliano C; Lovati E; Pietra C
    Front Pharmacol; 2016; 7():263. PubMed ID: 27630563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Oral Promethazine on Human Whole-Body Motion Perceptual Thresholds.
    Diaz-Artiles A; Priesol AJ; Clark TK; Sherwood DP; Oman CM; Young LR; Karmali F
    J Assoc Res Otolaryngol; 2017 Aug; 18(4):581-590. PubMed ID: 28439720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Various anti-motion sickness drugs and core body temperature changes.
    Cheung B; Nakashima AM; Hofer KD
    Aviat Space Environ Med; 2011 Apr; 82(4):409-15. PubMed ID: 21485398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets.
    Nakayama H; Yamakuni H; Higaki M; Ishikawa H; Imazumi K; Matsuo M; Mutoh S
    J Pharmacol Sci; 2005 Aug; 98(4):396-403. PubMed ID: 16079468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs.
    Bountra C; Gale JD; Gardner CJ; Jordan CC; Kilpatrick GJ; Twissell DJ; Ward P
    Oncology; 1996 Jun; 53 Suppl 1():102-9. PubMed ID: 8692545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
    Dornhoffer J; Chelonis JJ; Blake D
    Otol Neurotol; 2004 Sep; 25(5):740-5. PubMed ID: 15354005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting.
    Mayhall EA; Gray R; Lopes V; Matteson KA
    Am J Emerg Med; 2015 Jul; 33(7):882-6. PubMed ID: 25921968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.
    Markham A; Sorkin EM
    Drugs; 1993 Jun; 45(6):931-952. PubMed ID: 7691500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group.
    Cubeddu LX; Pendergrass K; Ryan T; York M; Burton G; Meshad M; Galvin D; Ciociola AA
    Am J Clin Oncol; 1994 Apr; 17(2):137-46. PubMed ID: 8141105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cybersickness provoked by head-mounted display affects cutaneous vascular tone, heart rate and reaction time.
    Nalivaiko E; Davis SL; Blackmore KL; Vakulin A; Nesbitt KV
    Physiol Behav; 2015 Nov; 151():583-90. PubMed ID: 26340855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No more than necessary: safety and efficacy of low-dose promethazine.
    Moser JD; Caldwell JB; Rhule FJ
    Ann Pharmacother; 2006 Jan; 40(1):45-8. PubMed ID: 16352779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties.
    Stott JR; Barnes GR; Wright RJ; Ruddock CJ
    Br J Clin Pharmacol; 1989 Feb; 27(2):147-57. PubMed ID: 2523720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review.
    Tramèr MR; Reynolds DJ; Stoner NS; Moore RA; McQuay HJ
    Eur J Cancer; 1998 Nov; 34(12):1836-44. PubMed ID: 10023303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.